Imaging Diagnostic Systems (IDS) develops scanner for colon cancer:
This article was originally published in Clinica
Executive Summary
Imaging Diagnostic Systems has started development of what it claims is a "revolutionary" laser scanner for the early detection of colon cancer. The scanner detects the fluorescence of molecules in the tumour region, to allow diagnosis of early-stage cancers on the surface of or within the colon wall. IDS believes the market is worth $500 million and hopes to capture 5% of new sales and 10% of replacement purchases. Colon cancer affects around 6% of the population in the US and Western Europe, with over 140,000 new diagnoses and 55,000 deaths per year.